IKK-16
Catalog No. A12836
IKK 16是针对IKK-2,IKK复合物和IKK-1的选择性IκB激酶(IKK)抑制剂,IC50分别为40 nM,70 nM和200 nM。
- Rulina AV, .et al. Distinct outcomes of CRL-Nedd8 pathway inhibition reveal cancer cell plasticity, Cell Death Dis, 2016, Dec 1;7(12):e2505 PMID: 27906189
Catalog Num | A12836 |
---|---|
M. Wt | 483.63 |
Formula | C28H29N5OS |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 873225-46-8 |
Synonyms | IKK 16, IKK16 |
SMILES | C1CCN(C1)C2CCN(CC2)C(=O)C3=CC=C(C=C3)NC4=NC=CC(=N4)C5=CC6=CC=CC=C6S5 |
IKK 16是针对IKK-2,IKK复合物和IKK-1的选择性IκB激酶(IKK)抑制剂,IC50分别为40 nM,70 nM和200 nM。
Targets
IKK2 (Cell-free assay) | IKK complex (Cell-free assay) | IKK1 (Cell-free assay) | ||
40 nM | 70 nM | 200 nM |
In vitro (25°C) | DMSO | 95 mg/mL (196.42 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 20.68 mL | 103.38 mL | 206.77 mL |
0.5 mM | 4.14 mL | 20.68 mL | 41.35 mL |
1 mM | 2.07 mL | 10.34 mL | 20.68 mL |
5 mM | 0.41 mL | 2.07 mL | 4.14 mL |
*The above data is based on the productmolecular weight 483.63. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.